Science and Technology Innovation Board Daily

(1) The Central Air Traffic Control Commission deploys and strengthens low-altitude air traffic control to the national air traffic control system;

(2) China's independent quantum computer runs a billion-level AI fine-tuning model for the first time;

(3) Beijing: Explore the pilot implementation of cross-border commissioned production of medical device products.

"Science and Technology Innovation Board Daily" on April 7 - The main contents of today's Science and Technology Innovation Board Evening News include: the Central Air Traffic Control Commission deployed to the national air traffic control system to strengthen the work of low-altitude air traffic control; China's autonomous quantum computer runs a billion-level AI fine-tuning model for the first time; Beijing: Explore the first trial of cross-border commissioned production of medical device products.

[Hot Spotlight].

News-in-brief:

The Ministry of Commerce held a roundtable meeting of U.S.-funded enterprises, and representatives of more than 20 U.S.-funded enterprises including Tesla attended the meeting

Ling Ji, Vice Minister of Commerce and Deputy Representative for International Trade Negotiations, presided over a roundtable meeting of U.S.-funded enterprises on April 6. Representatives of more than 20 U.S. companies, including Tesla, GE Healthcare, and Medtronic, attended the meeting.

Ling Ji said that when President Xi Jinping met with representatives of the international business community on March 28, he fully affirmed the important role played by foreign-funded enterprises in China's reform, opening up and modernization. We will resolutely implement the spirit of President Xi Jinping's important speech, no matter how the international situation changes, China will unswervingly promote reform and opening up, multilateralism is the inevitable choice to solve the difficulties and challenges facing the world, China's door will only open wider and wider, and the policy of using foreign investment has not changed and will not change. The Ministry of Commerce will, as always, provide guarantees for foreign-funded enterprises in China, including US-funded enterprises, protect the legitimate rights and interests of foreign-funded enterprises in accordance with the law, and actively promote the resolution of foreign-funded enterprises' problems and demands. China was, is, and will be a fertile ground for ideal, safe and promising investment by foreign businessmen.

Ling Ji stressed that in recent days, the United States has announced under various pretexts that it has imposed indiscriminate tariffs on all trading partners, including China, which has seriously undermined the rules-based multilateral trading system and seriously infringed upon the legitimate rights and interests of all countries. China's countermeasures not only firmly safeguard the legitimate rights and interests of U.S.-funded enterprises, but also push the U.S. back to the right track of the multilateral trading system. The root cause of the tariff problem is in the United States, and it is hoped that U.S.-funded companies will trace the root causes, clarify the cause and effect, raise their rational voices, and take pragmatic actions to jointly maintain the stability of the global production and supply chain and promote win-win cooperation.

Representatives of participating enterprises said that through this meeting, a positive signal was sent, and they fully understood that the Chinese government has been consistent in implementing the spirit of President Xi Jinping's important speech on March 28 and will report to the headquarters in a timely manner. At the meeting, the representatives of the enterprises reflected the problems encountered in the current investment and operation, and the heads of the relevant departments and bureaus of the Ministry of Commerce responded one by one on the spot.

The Central Air Traffic Control Commission has deployed and strengthened low-altitude air traffic control work to the national air traffic control system

In order to ensure the high-quality development of general aviation and low-altitude economy, the Central Air Traffic Management Commission issued special measures, focusing on improving the low-altitude management system, optimizing the allocation of airspace resources, improving the quality and efficiency of operation services, consolidating basic support capabilities, and strengthening the management of air and air use in accordance with the law.

According to the relevant person in charge of the Central Air Traffic Control Office, there are currently more than 2.2 million unmanned aerial vehicles registered with real names nationwide, and more than 3,200 general aviation aircraft; In 2024, the air traffic control system will ensure more than 340 million unmanned aircraft flights, more than 26 million hours, and more than 1.2 million general aviation flights.

The person in charge said that at present, the Central Air Traffic Control Office is working with relevant departments to accelerate the construction of an integrated low-altitude air traffic control system, and clarify the division of responsibilities such as construction management, service guarantee, and safety supervision; Establish a more flexible and efficient airspace management model, effectively release airspace resources, and achieve a high level of dynamic balance between airspace supply and demand; Gradually improve the low-altitude air traffic control infrastructure to achieve wide-area coverage and full-time support of the service guarantee network; Continuously improve the low-altitude safety supervision system and greatly improve the level of safety assurance; Construct and form a rule and regulation system that adapts to the new scenarios of traditional general aviation and low-altitude economy, so that the majority of low-altitude users can carry out diversified low-altitude flight activities conveniently in accordance with the law.

The Ministry of Foreign Affairs responded to questions related to TikTok

The Ministry of Foreign Affairs held a regular press conference on the afternoon of April 7, during which a reporter asked questions about issues related to TikTok. Foreign Ministry Spokesperson Lin Jian: On the issue of TikTok, China has made clear its principled position on many occasions. China will handle relevant issues in accordance with China's laws and regulations, and the US should provide an open, fair, just and non-discriminatory business environment for Chinese companies operating in the US.

China's independent quantum computer "Origin Wukong" is the world's first to run a billion-level AI fine-tuning large model

The reporter learned from the Anhui Provincial Quantum Computing Engineering Research Center that Origin Quantum, Hefei Comprehensive National Science Center Artificial Intelligence Research Institute and other institutions jointly tackled key problems and ran the world's first billion-parameter AI large model fine-tuning task on the real machine of China's third-generation independent superconducting quantum computer "Origin Wukong". Chen Zhaoyun, an associate researcher at the Institute of Artificial Intelligence of Hefei Comprehensive National Science Center, said: "This is the first large-scale model task of quantum computing to be 'real machine in real combat', which proves that the existing hardware can initially support the fine-tuning of large-scale models. ”

Beijing: Explore the first trial of cross-border commissioned production of medical device products

Nine departments, including the Beijing Municipal Medical Security Bureau, issued the "Several Measures to Support the High-quality Development of Innovative Pharmaceuticals in Beijing (2025)". Among them, it is proposed to support the cross-border segmented production of overseas drug marketing authorization holders, and carry out the pilot of segmented production of biological products. Support multinational enterprises to apply for drug production licenses in the form of commissioned production and list them in Beijing. Explore and carry out cross-border commissioned production of medical device products.

Shenzhen: Focus on high-end medical imaging, medical robots, high-performance implantable interventional devices, etc., and support the development of high-end medical device products

Shenzhen issued the "Several Measures to Support the Development of Pharmaceuticals and Medical Devices in the Whole Chain of Shenzhen". The measures propose to focus on high-end medical imaging, medical robots, high-performance implantable interventional devices, in vitro diagnosis, life monitoring and support, artificial intelligence-assisted diagnosis systems, etc., and support the development of high-end medical device products. Increase support for Class II and III medical devices that have been approved for the first time through the special approval procedures for national and provincial innovative medical devices. For the R&D and production of innovative pet medical devices that meet the relevant standards, 20% of the actual investment in R&D will be supported, and the annual support for a single enterprise shall not exceed 5 million yuan.

Depth:

[Announcement of the Science and Technology Innovation Board].

Tiandeyu: Net profit in the first quarter increased by 117% year-on-year

Tiandeyu (688252.SH) announced that it is expected to achieve a net profit of 70.5681 million yuan in the first quarter of 2025, a year-on-year increase of 116.96%, and the performance growth is due to the company's continuous development of new products, new customers and new markets. After long-term R&D investment and technology accumulation, the company has achieved a competitive advantage in the differentiated product market, and the company's business has entered a rapid stage of development.

Chengda Bio: The tender offer period of Shaoguan Gaoteng expires, and the stock will resume trading tomorrow

Chengda Biotechnology (688739.SH) announced that the tender offer period of Shaoguan Gaoteng Enterprise Management Co., Ltd. has expired, and the total number of pre-offered shareholder accounts is 19, and the total number of pre-offered shares is 6,939 shares, accounting for about 0.0017% of the company's total share capital. After the completion of the acquisition, Shaoguan Gaoteng directly holds 6,939 shares of Chengda Biotech, accounting for about 0.0017% of the company's total share capital, and the company's equity distribution still meets the listing conditions, and the listing status will not be affected. The company's shares will resume trading from April 8, 2025.

Canqin Technology: Net profit in 2024 will increase by 23.66% year-on-year

Canqin Technology (688182.SH) announced that Canqin Technology released its 2024 annual report, the company's operating income in 2024 will be 411 million yuan, a year-on-year increase of 11.09%, and the net profit attributable to shareholders of listed companies will be 57.7943 million yuan, a year-on-year increase of 23.66%. The company intends to distribute a cash dividend of 0.75 yuan (tax included) to all shareholders for every 10 shares based on the total share capital registered on the record date of the implementation of equity distribution.

Aojie Technology: Net loss of 693 million yuan in 2024

Aojie Technology (688220.SH) released its annual report, with a net loss of 693 million yuan in 2024.

Aerospace Technology: Net profit in 2024 will be 189 million yuan, a year-on-year increase of 1.63

Aerospace Technology (688239.SH) released its annual report, achieving a net profit attributable to the parent company of 189 million yuan in 2024, a year-on-year increase of 1.63%. It is proposed to distribute 2.2 yuan for every 10 shares, and increase 3 shares for every 10 shares.

Canqin Technology: It is planned to acquire 52% of the shares of latitude antenna for 20.8 million yuan

Canqin Technology (688182.SH) announced that the company intends to use its own funds of 20.8 million yuan to purchase 52% of the equity of latitude antenna held by Xiecheng Microwave. After the completion of this transaction, Latitude Antenna will become a holding subsidiary of the company. This transaction does not constitute a connected transaction, nor does it constitute a material asset restructuring. The transaction price is based on the appraisal report, combined with the analysis and verification of the target company's price-earnings ratio, price-to-book ratio, future earnings and valuation level of the same industry, and is determined through negotiation between all parties.

Yingke Regeneration: It is planned to repurchase the company's shares for 40 million yuan to 80 million yuan

INTCO Regeneration (688087.SH) announced that the company intends to use its own funds and special loans for share repurchase to repurchase part of the company's issued RMB ordinary shares (A shares) in a centralized bidding transaction, with a repurchase amount of not less than 40 million yuan (inclusive) and no more than 80 million yuan (inclusive). The repurchased shares will be used for employee stock ownership plans and/or equity incentives at an appropriate time in the future.

Guangge Technology: The actual controller proposed to repurchase shares for 10 million yuan to 20 million yuan

Guangge Technology (688450.SH) announced that the company's board of directors recently received a proposal from Jiang Mingwu, the actual controller, chairman and general manager, to repurchase part of the company's shares through centralized bidding transactions, with a total amount of not less than 10 million yuan (inclusive) and no more than 20 million yuan (inclusive), and the repurchase price is not higher than 150% of the average trading price of the company's shares in the 30 trading days before the board of directors passed the repurchase resolution, and the repurchased shares are intended to be used for the implementation of employee stock ownership plans or equity incentives.

Gaotest shares: the shareholder inquiry transfer price is 8.30 yuan / share

Gaotse shares (688556.SH) announced that according to the inquiry subscription on April 7, 2025, the preliminarily determined transfer price of this inquiry is 8.30 yuan per share. The number of institutional investors participating in this inquiry and transfer quotation is 11, and the transferee is preliminarily determined to be 11 institutional investors, and the total number of shares to be transferred is 25,741,300 shares.

[Venture capital vane].

BWI Zhixing received a strategic financing of RMB500 million

Recently, Jingxi Zhixing Zhangjiakou Automotive Electronics Co., Ltd. completed a strategic financing of 500 million yuan, and the investor in this round is Shenzhen Investment Holdings. BWI Intelligent is a supplier of automotive chassis suspension and braking systems, which is part of BWI Heavy Industries. According to the data of the Venture Capital Connect of the Financial Associated Press, taking April 2025 as the forecast base time, the financing forecast probability for the next two years is 63.96%.

Tongjia Hongrui completed 500 million yuan in Series C financing

Recently, Beijing Tongjia Hongrui Technology Co., Ltd. completed a 500 million yuan Series C financing, led by Shunxi Fund, followed by Shanghai Ruili Investment, Mirae Asset Capital, and Dachen Caizhi. Tongjia Hongrui is a pan-semiconductor industry dry vacuum pump equipment and system technology service provider. According to the data of the Venture Capital Connect of the Financial Associated Press, taking April 2025 as the forecast base time, the financing forecast probability for the next two years is 85.42%.

Mitouke completed about 10 million yuan of Pre-A round of financing

Mitouke Biopharma is a biopharmaceutical company focusing on the development of cell-based drugs for common diseases in elderly pets. Recently, Mitouke has completed a Pre-A round of financing of about 10 million yuan, and the investor in this round is Qinzhi Capital. The funds from this round of financing will be used to accelerate the R&D and clinical trial process of cell drugs, with a view to launching drugs that can effectively treat diseases in elderly pets as soon as possible, improve the quality of life of elderly pets, and enhance the happiness of pet owners. According to the data of the Venture Capital Connect of the Financial Associated Press, taking April 2025 as the forecast base time, the probability of financing in the next two years is 52.44%. Collection

Read 2497

I want to comment

You are welcome to post valuable comments, advertisements and discord comments will be deleted, and comments will be banned from your account.